Bio-Techne (TECH) said Monday that it has begun shipping its "Leo" system," which is powered by the company's "Simple Western" medical diagnostic tools.
Bio-Techne said "Leo" builds on "Simple Western" platforms offering automatic protein size resolution and antibody-based protein detection by improving sample throughput and enhancing the reproducibility of protein quantitation.
The company said Leo allows for simultaneous processing of up to 100 samples in a single three-hour run.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.